Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke

NCT07115511 is registered in ClinicalTrials.gov with Tianjin Huanhu Hospital as lead sponsor.

NCT NCT07115511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke
Lead sponsor
Tianjin Huanhu Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2024
Completion date
November 30, 2026
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke